Project Number ARUK-PPG2014B-3 Agency/Funding Organization Alzheimer's Research UK Funding Year 2014 View Full Project Details for Double-blind randomised crossover placebo-controlled pilot trial with intra-nasal Oxytocin to increase social cognitive function and reduce carer burden in frontotemporal dementia. Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Researcher and Organization Principal Investigator Hornberger, Michael Principal Investigator First Name Michael Principal Investigator Last Name Hornberger Awardee Organization UNIVERSITY OF CAMBRIDGE Contact PI Country United Kingdom Project Detail FY Overall Cost $29,827 Funding Organization Agency/Funding Organization Alzheimer's Research UK Funding Organization Country United Kingdom
